Showing results (361-370 of 369) with videos related to
Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 369 results.
Journal of Hematotherapy|November 22, 1997
CD34+ cells can be selected efficiently from cryopreserved peripheral blood progenitor cells and can retain their proliferative potentialM J Alcorn, T L Holyoake, L J Richmond, et al.Journal of Hematotherapy|August 1, 1997
Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of DirectorsE J ShpallJournal of Hematotherapy|August 1, 1997
Neutrophil maturation of CD34+ cells from peripheral blood and bone marrow in serum-free culture medium with PIXY321 and granulocyte-colony stimulating factor (G-CSF)S L Smith, J G Bender, C Berger, et al.Journal of Hematotherapy|August 1, 1997
Animal serum-free culture of purified human CD34+ cells: amplification of progenitors from G-CSF and GM-CSF-mobilized peripheral bloodL R Schain, S Jain, M Wysocki, et al.Journal of Hematotherapy|June 11, 1998
Distribution of mobilized progenitor cells in the buffy coat of the haemonetics MCS3p cell separator: a study to optimize the collection of progenitors by leukapheresisM Ghielmini, U Pfister, E Zucca, et al.Journal of Hematotherapy|May 23, 1998
CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftmentS J Noga, A Seber, J M Davis, et al.Journal of Hematotherapy|May 23, 1998
CD19 selection improves the sensitivity of B cell lymphoma detectionR E Pugh, M A Bitter, E J Shpall, et al.Journal of Hematotherapy|May 23, 1998
Sequential CD34+ and CD4+ cell selection from leukapheresis componentsI J Webb, M Beach, J F Daley, et al.Journal of Hematotherapy|February 1, 1997
Large-scale isolation of CD34+ cells using the Amgen cell selection device results in high levels of purity and recoveryI McNiece, R Briddell, G Stoney, et al.Pageof 37